The Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences (QIBEBT) became a member of the Cluster Industrial Biotechnology (CLIB2021) on Nov. 19, 2013.
The Cluster intends to promote industrial biotechnology in science and application of industrial biotechnology in commercial industrial activities. To achieve this purpose, in the field of industrial biotechnology, the Cluster creates a working and communication platform for companies and scientific institutes, and expands cooperation among industry, small and mid-sized enterprises (SMEs).
The Cluster also focuses on promotion of excellence in science and education inside and outside universities, and the international dialoge between research institutes. QIBEBT will serve as the only Chinese research body within CLIB2021.
QIBEBT will be involved in this partnership to expand the basic science research capacity. QIBEBT has developed a market-oriented value chain from upstream biotechnologies like genomics, metabolomics, proteomics, biocatalysis and biotransformation, to downstream processing.
QIBEBT scientists are excited to participate in this Cluster. “The Institute is committed to the ideals and goals of the CLIB2021," said Dr. LU Xuefeng, deputy director of QIBEBT. "We hope to bring our unique faculty, expertise and facility resources to the Cluster to expand our research competences to members and to invite Cluster researchers and postgraduates to QIBEBT for academic exchange and collaboration. We strongly believe that this academia-to-industry partnership is critical to the institute’s mission.”
CLIB2021, headquartered in Germany, is an international open innovation cluste of large companies, SMEs, academic institutes and universities as well as other stakeholders active in biotechnology and the bioeconomy as a whole. The membership comprises an international share of about 30%, and about a hundred members from industry, SMEs, universities and research institutions, investors and founders, and business support & networks.